论文部分内容阅读
目的:评价卡孕栓与缩宫素联用预防高危妊娠剖宫产患者术中和术后出血的临床疗效。方法:将医院收治行剖宫产的120例产妇分为实验组和对照组,各60例;两组患者均在胎儿娩出后与胎盘娩出前均予注射2.5~5.0 U缩宫素;实验组患者在切开腹膜时予产妇舌下含服卡孕栓1 mg,术后经直肠置入1 mg卡孕栓;对照组患者除注射缩宫素外不使用其他药物;比较两组产妇术中平均出血量、产后24 h出血量、术后6 h血压及不良反应的发生情况。结果:实验组产妇术中平均出血量及产后24 h出血量均低于对照组(P<0.05);两组产妇术后6 h血压监测结果比较(P>0.05);实验组产妇予卡孕栓后7例出现轻微不良反应,均无需特殊处理后自动恢复,无感染发生,对照组未发生不良反应;两组比较其差异无统计学意义(P>0.05);两组产妇术后泌乳量经比较无统计学意义(P>0.05)。结论:卡孕栓与缩宫素联用能有效预防高危妊娠剖宫产术中术后出血,且对产妇血压无明显影响。
Objective: To evaluate the clinical efficacy of carbamazepine in combination with oxytocin in the prevention of intraoperative and postoperative bleeding in cesarean section in high-risk pregnancies. Methods: 120 pregnant women who received cesarean section in the hospital were divided into experimental group and control group (60 cases each). Both groups were injected with 2.5-5.0 U of oxytocin after the fetus was delivered and the placenta was delivered. The experimental group The patients underwent sublingual buccal suppository 1 mg after incision of the peritoneum and 1 mg carboplatin suppository after the operation. Patients in the control group received no other drugs except oxytocin; Average amount of bleeding, 24 h postpartum hemorrhage, 6 h postoperative blood pressure and adverse reactions occurred. Results: The average amount of bleeding in the experimental group and the amount of bleeding at 24 hours after delivery were lower than those in the control group (P <0.05). The blood pressure monitoring results at 6 hours after operation in both groups were significantly higher than those in the control group (P> 0.05) There were no adverse reactions in the control group after 7 days of thrombolysis. No significant difference was found between the two groups (P> 0.05). The postpartum lactation volume The comparison was not statistically significant (P> 0.05). Conclusion: The combination of carbamazepine and oxytocin can effectively prevent postoperative bleeding during cesarean section in high-risk pregnancies and has no significant effect on maternal blood pressure.